ATYR
aTyr Pharma
ATYR
ATYR
39 hedge funds and large institutions have $39.2M invested in aTyr Pharma in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
64% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 11
Holders
39
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$4.6M | |
| 2 | +$1.95M | |
| 3 | +$275K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$68K |
| 5 |
DTL
Dynamic Technology Lab
Singapore
|
+$68K |
Top Sellers
| 1 | -$919K | |
| 2 | -$601K | |
| 3 | -$205K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$204K |
| 5 |
Goldman Sachs
New York
|
-$162K |